TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cardiac Histopathological Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived brace comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hair preservation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grade 1 or above ADE
Endpoint domain: Adverse events/effects
Primary endpoint: Function - ALSFRS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 18-month event-free survival (EFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Pattern of neonatal seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of CAR-T-cell treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Primary objective
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Identification of HFPEF using NT-proBNP cut-offs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Skin Physiological Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: onset of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: application time for endovascular intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain intensity change from baseline to 72 hours post dose
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Average Total App Openings
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Cognitive leisure activity levels
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Leicester Cough Questionnaire (LCQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of symptomatic cerebral hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of NOD2 ligand in fecal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Perioperation blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Optimal SUVmax threshold for predicting pCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Respiratory morbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of patients returning to sports
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline in DN4 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in serum HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in serum vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Exhaled carbon monoxide (CO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-report of daily cigarette and e-cigarette use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Achieving a Best Overall Response (BOR) of Complete Remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiotracer avidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of contact allergic dermatitis or adverse skin reaction at 1 week post surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of contact allergic dermatitis or adverse skin reaction at 2-3 weeks post surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Functional connectivity of orbital frontal cortex (OFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in tumor microenvironment during radiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in fMRI during radiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Procedural success (freedom from atrial arrhythmias)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of acute procedure-related complications and major adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of liver elastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of liver fat quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rutgeerts Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Engagement/adherence to protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attrition/Drop out
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cervical Radiculopathy Impact Scale (CRIS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety and dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in strength recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TEEs within 45 days following VKA reversal treatment
Endpoint domain: Mortality/survival
Primary endpoint: 6-month target lesion primary patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pulse oximeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CASA Q scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in Right ventricle (RV) / Left Ventricle (LV) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 4-year rwDFS rate
Endpoint domain: Mortality/survival
Primary endpoint: 3-year OS
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants receiving at least 10 out of 15 rTMS sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants in the active rTMS arm experiencing an rTMS-emergent adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change of medial prefrontal cortex and dorsal anterior cingulate cortex activity on fMRI during the Drug Stroop Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of participants who achieve 3 weeks of abstinence during the final 12 weeks of the trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Tolerated Dose (MTD) of ABD-3001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour pad weigh test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in antibody titer concentration to vaccination-Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in antibody titer concentration to vaccination-Skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete evacuation time of non-invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hsCRP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PN response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core beliefs strength
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Amount of fat mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of subjects meeting Subject Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with menstrual bleeding < 80 mL and a reduction of ≥50% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Sensitivity and specificity of the Simplified Diagnosis Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of parturients requiring additional uterotonic agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average Relative Index Value Following a Hemodialysis Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Validation of leva measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini Mental State Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: World Health Organization Quality of Life Scale Elderly Module
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of participants in clinical remission at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with common patterns of retinal degeneration observed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the concentration-time curve of BI 685509 in plasma (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of the ISI score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Patient insomnia perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Newborn Anthropometric Characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensive Care Unit (ICU) length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma Concentrations of Pociredir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical changes before COPD exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medically attended adverse events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Closed-loop performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with acute procedural success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Peak Oxygen Consumption (VO2max), mL/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on Cognitive Function Self-Assessment Scale (CFSS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Score on PHQ-8
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of moderate and severe hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in State Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of smart inhaler device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of smart inhaler
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Usability of smart inhaler
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence rate of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Modified USPHS Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily changes of mindfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily changes of rumination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily changes of positive and negative affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily changes of emotional distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Presence/absence of Archaea in saliva samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Benefit of blood cell transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Body mass measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain intensity after adequate treatment of sleep disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in objective sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Time to diagnosis of antibody-mediated rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Metabolic energy cost
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sit-to-stand/stand-to-sit symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Five Facet Mindfulness Questionnaire-short form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weekly changes of 10-item Kessler Psychological Distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weekly changes of Overall Anxiety Severity and Impairment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weekly changes of Overall Depression Severity and Impairment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weekly changes of Insomnia severity index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Weekly changes of Pittsburgh sleep quality index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Presence of esophageal varices needing treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: TBUT change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of emerging ESR1 mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Leaks
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ocular symptoms and ocular treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant change in visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes in blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serologic response to vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in office Systolic Blood Pressure (SBP) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EIT test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PE recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiorespiratory decompensation or collapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with order of Low-dose CT for lung cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Achieving Adapted Mayo score Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Asthma Control Questionnaire 6 (ACQ-6) score from Baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with well-controlled asthma (ACQ-6 score ≤ 0.75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of NOWDx HSV-2 Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal PEEP level at spine position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Optimal PEEP level at prone position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: WaLIDD score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: McGill Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PFSD scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful stent recanalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Subjects Satisfied
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Corneal Epithelium health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal Nerve health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Skeletal maxillary width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Rate of Survival
Endpoint domain: Mortality/survival
Primary endpoint: Mean nocturnal SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in UCLA Loneliness Scale Version 3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical burden caused by postponement of elective surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mental burden caused by postponement of elective surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: frequency of vaccine events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects with positive T-cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects able to suppress viral propagation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Score of post-extubation cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static tensile load bearing capacity to reach a 50-pound load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elbow range of motion in flexion/extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power in Watts generated on rowing machine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of BGB-R046
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Systolic and Diastolic Blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rate in beats per minute (bpm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with normal or abnormal psychological status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with HbA1c less than 6.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SF-36 (subjective health and wellbeing)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of DIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of CYP450 Substrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve from Time Zero to Time of Last Quantifiable Concentration (AUClast) of CYP450 Substrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve from Time Zero to Infinity (AUCinf) of CYP450 Substrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NADPH activation in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Child Appetite Regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline ProBNPage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Clinical Laboratory Test Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Electrocardiogram (ECG) Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the modified Physical Performance Test (PPT)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gain (VHITG) of the vestibulo-ocular reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in duodenal polyp burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes